Borgstrom and Yale New Haven Health Help Guide a Hard-hit Portion of Connecticut Through Perilous Times
In addition to advising Governor Lamont’s administration on the state’s health response, Borgstrom and other members of the Health Response Team make sure that allocations of equipment, facilities, and personnel in suddenly overburdened health facilities meet the needs of patients.
Feet Don’t Fail Me Now: 8 Tips for Healthy Walking During the COVID Crisis
Walking has become a popular form of exercise during the COVID-19 pandemic. Afterall, it is easy for people to stay six feet apart, it lets folks enjoy the fresh air and it provides numerous physical and mental health benefits.
An ‘Epic’ pushback as U.S. prepares for new era of empowering patient health data
Epic, the largest electronic health record company in the U.S., launched an effort last week to persuade hospital CEOs across the country to fight recent efforts by the federal government to ensure that patients can easily access their electronic health data.Source: STAT
Study: Hospital readmission policy did not increase patients’ mortality risk
The Obamacare program intended to reduce the risk of patients being readmitted after hospitalizations for heart attacks, heart failure, and pneumonia has not caused an increase in mortality risk for patients in emergency departments or observational units, according to a new report.
Cardiologist Creates Podcast to Encourage Patients to Become More Involved in Health Care Decisions
Harlan Krumholz, MD, had been a cardiologist and professor of social and policy studies at Yale School of Medicine for years when Claudine Litman, a former designer and student, introduced him to Charles and Ray Eames’ philosophy for making iconic furniture: Never delegate understanding.Source: Stanford Medicine
Study Exposes Surprise Billing by Hospital Physicians
“When physicians whom patients do not choose and cannot avoid bill out of network, it exposes people to unexpected and expensive medical bills and undercuts the functioning of U.S. health care markets,” said Zack Cooper, associate professor of public health at the Yale School of Public Health and in the Department of Economics who is one of the study’s authors.
Health Care Industry Is a Major Source of Harmful Emissions
Climate change presents an unprecedented public health emergency and the global healthcare sector is contributing to the worldwide crisis, argues Jodi Sherman, M.D., associate professor of anesthesiology at the Yale School of Medicine in a commentary published Aug. 2 in the Journal of the American Medical Association.
Text Messages Show Promise as Next Step for Improving Heart Health in China
Motivational text messages are a well-liked, feasible new way to provide additional support to Chinese patients with heart disease, reports a preliminary study by researchers at Yale and in China. However, the study did not prove that these targeted text messages led to an improvement in blood pressure control amongst the recipients, the intended outcome.
Don't Jump for Joy over New FDA-approved Postpartum Depression Medicine Yet
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Sciences cautions new mothers who may consider taking the new FDA-approved medication for postpartum depression in an opinion piece published in USA Today.Source: USA Today
Doctors asking how much post-surgical follow-up is needed
On Saturday, Reisman, 52, a former New York lawyer who now freelances for the Shoreline Times, held a party to celebrate two decades of survival. Looking back on the years after her surgery, Reisman said the fear that the cancer could return was compounded by the anxiety she felt about the multiple MRIs she was required to undergo to make sure it hadn’t. Reisman’s experience has buttressed the concern of Dr. Cary Gross, her brother-in-law, a professor of medicine and epidemiology at the Yale School of Medicine. With new studies showing that multiple surveillance procedures don’t necessarily improve patient outcomes in at least some cancers, he is concerned about whether aggressive post-treatment testing is really necessary, given the anxiety, cost and even occasional false positive results that accompany it.Source: New Haven Register